GlassScriptPhysician profile
Alisha Morgan
NPI 1710281332
$785.02
in general payments reported to CMS, 2019-2025
16 companies · $49.84 in 2025
The $49.84 reported for 2025 was less than what a typical Advanced Practice Midwife provider received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $157 · 2022: $302 · 2023: $163 · 2024: $113 · 2025: $49.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $325.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $179.00 | 2022-2023 | |
| Abbvie INC. | $126.75 | 2021-2022 | |
| Biogen, INC. | $77.86 | 2024-2025 | Zurzuvae |
| Channel Medsystems, INC. | $60.82 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.92 | 2021-2022 | |
| Exeltis, USA INC. | $49.16 | 2021-2024 | Slynd |
| Agile Therapeutics, INC. | $44.38 | 2022 | |
| Avion Pharmaceuticals | $36.88 | 2021-2022 | |
| Axonics, INC. | $31.46 | 2021-2024 | Axonics |
| Organon LLC | $31.16 | 2023-2024 | |
| Astellas Pharma US INC | $18.33 | 2024 | Veozah |
| Hologic Sales and Service, LLC | $16.90 | 2022 | |
| Gynesonics, INC. | $16.52 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Lupin INC. | $15.76 | 2021 | |
| Mayne Pharma Commercial LLC | $14.77 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $11.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alisha Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.